SCHEMBL13232148

SCHEMBL13232148

BCN1C(=O)CCC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13232234 1.00 — —
SCHEMBL2379257 0.80 — —
SCHEMBL17946144 0.80 — —
SCHEMBL11463019 0.78 — —
SCHEMBL11479479 0.78 — —
SCHEMBL11288962 0.78 — —
SCHEMBL4330615 0.77 CHRM2 (0.49) —
SCHEMBL8282939 0.75 CHRM2 (0.60) —
SCHEMBL4338414 0.75 CHRM2 (0.47) —
SCHEMBL5331770 0.75 CHRM2 (0.47) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362054-B2 Therapeutic substituted lactams ALLERGAN, INC. (US) 2013-01-29 — — US disclosed
US-20100168189-A1 THERAPEUTIC SUBSTITUTED LACTAMS ALLERGAN, INC. 2010-07-01 — — US disclosed
Send feedback